Answers are grounded in this paper and cite their sources.
This study aimed to evaluate the efficacy and safety of total glucosides of paeony (TGP) in patients with primary Sjögren's syndrome (pSS).
No takes yet. Share an insight, caveat, or question.
Cui et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: